DE69823869D1 - Pharmazeutische hydrogelformulierungen, vorrichtungen zur arzneistoffabgabe und verfahren - Google Patents
Pharmazeutische hydrogelformulierungen, vorrichtungen zur arzneistoffabgabe und verfahrenInfo
- Publication number
- DE69823869D1 DE69823869D1 DE69823869T DE69823869T DE69823869D1 DE 69823869 D1 DE69823869 D1 DE 69823869D1 DE 69823869 T DE69823869 T DE 69823869T DE 69823869 T DE69823869 T DE 69823869T DE 69823869 D1 DE69823869 D1 DE 69823869D1
- Authority
- DE
- Germany
- Prior art keywords
- devices
- drug delivery
- hydrogel formulations
- pharmaceutical hydrogel
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/987,372 US6039977A (en) | 1997-12-09 | 1997-12-09 | Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods |
US987372 | 1997-12-09 | ||
PCT/US1998/025120 WO1999029348A1 (en) | 1997-12-09 | 1998-12-01 | Pharmaceutical hydrogel formulations, drug delivery devices and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69823869D1 true DE69823869D1 (de) | 2004-06-17 |
DE69823869T2 DE69823869T2 (de) | 2005-05-19 |
Family
ID=25533223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69823869T Expired - Lifetime DE69823869T2 (de) | 1997-12-09 | 1998-12-01 | Pharmazeutische hydrogelformulierungen, vorrichtungen zur arzneistoffabgabe und verfahren |
Country Status (16)
Country | Link |
---|---|
US (1) | US6039977A (de) |
EP (1) | EP1037667B1 (de) |
JP (1) | JP2001525377A (de) |
KR (1) | KR100568482B1 (de) |
CN (1) | CN1147319C (de) |
AR (1) | AR017197A1 (de) |
AT (1) | ATE266422T1 (de) |
AU (1) | AU1535799A (de) |
CA (1) | CA2313642C (de) |
DE (1) | DE69823869T2 (de) |
DK (1) | DK1037667T3 (de) |
ES (1) | ES2221228T3 (de) |
PT (1) | PT1037667E (de) |
TW (1) | TWI231214B (de) |
WO (1) | WO1999029348A1 (de) |
ZA (1) | ZA9810641B (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
GB0005016D0 (en) * | 2000-03-01 | 2000-04-26 | Jumik Technologies Limited | PVA-Containing compositions |
IL152360A0 (en) | 2000-04-19 | 2003-05-29 | Genentech Inc | Sustained release formulations |
KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
EP1372729B1 (de) * | 2001-02-23 | 2009-04-08 | Genentech, Inc. | Erodierbare polymere zur injektion |
CA2443326A1 (en) * | 2001-04-04 | 2002-10-17 | Alza Corporation | Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition |
PT1397155E (pt) * | 2001-06-21 | 2015-12-07 | Genentech Inc | Formulação de libertação sustentada |
DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
ITMI20012060A1 (it) * | 2001-10-05 | 2003-04-05 | Recordati Chem Pharm | Nuovi eterocilcli n-acilati |
AU2002351164A1 (en) * | 2001-11-26 | 2003-06-10 | Molecular Reflections, Inc. | Microscale immobilization of molecules using a hydrogel and methods of use thereof |
US6975902B2 (en) * | 2002-06-28 | 2005-12-13 | Alza Corporation | Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof |
US20040158194A1 (en) * | 2003-02-06 | 2004-08-12 | Wolff Andy And Beiski Ben Z. | Oral devices and methods for controlled drug release |
CA2546399A1 (en) * | 2003-11-19 | 2005-06-09 | Alza Corporation | Methods for preparing polymeric buffer formulations for electrotransport applications |
US20070212402A1 (en) * | 2003-12-05 | 2007-09-13 | Rooven Qainton V | Patch |
CN100386073C (zh) * | 2004-03-03 | 2008-05-07 | 杭州民生药业集团有限公司 | 一种经皮给药系统 |
US7491263B2 (en) * | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
WO2006055729A1 (en) * | 2004-11-16 | 2006-05-26 | Transcutaneous Technologies Inc. | Iontophoretic device and method for administering immune response-enhancing agents and compositions |
US20070106138A1 (en) * | 2005-05-26 | 2007-05-10 | Beiski Ben Z | Intraoral apparatus for non-invasive blood and saliva monitoring & sensing |
EP1893278A2 (de) * | 2005-06-03 | 2008-03-05 | Trans-Dermal Patents Company, LLC | System zur abgabe eines arzneimittels |
US20090143761A1 (en) * | 2005-06-03 | 2009-06-04 | Transdermal Patents Company, Llc | Agent delivery system and uses of same |
US20090214625A1 (en) * | 2005-07-15 | 2009-08-27 | Mizuo Nakayama | Drug delivery patch |
JP4969812B2 (ja) * | 2005-07-22 | 2012-07-04 | 久光製薬株式会社 | ハイドロゲル組成物 |
JP2009505805A (ja) | 2005-08-31 | 2009-02-12 | アルザ・コーポレーシヨン | アニオン性薬剤を電気的輸送送達するための陰極 |
WO2007041322A2 (en) * | 2005-09-30 | 2007-04-12 | Tti Ellebeau, Inc. | Iontophoretic delivery of active agents conjugated to nanoparticles |
JP2009522011A (ja) | 2005-12-30 | 2009-06-11 | Tti・エルビュー株式会社 | 活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法 |
AU2007227312A1 (en) * | 2006-03-21 | 2007-09-27 | Alza Corporation | Hydratable polymeric ester matrix for drug electrotransport |
US8246973B2 (en) * | 2006-06-21 | 2012-08-21 | Advanced Cardiovascular Systems, Inc. | Freeze-thaw method for modifying stent coating |
US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
EP2063863A2 (de) * | 2006-08-29 | 2009-06-03 | Alza Corporation | Elektrotransport von wirkstoffen mit hydratationsmessung des hydratisierbaren reservoirs |
US20080193514A1 (en) * | 2006-11-02 | 2008-08-14 | Transcu Ltd. | Compostions and methods for iontophoresis delivery of active ingredients through hair follicles |
WO2008082558A2 (en) | 2006-12-20 | 2008-07-10 | Alza Corporation | Anode for electrotransport of cationic drug |
WO2008087803A1 (ja) * | 2007-01-16 | 2008-07-24 | Hokkaido University | 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤 |
US20080234627A1 (en) * | 2007-03-22 | 2008-09-25 | Wanda Dent | Pivotally engaged multiple part electrotransport drug delivery device |
NZ582049A (en) * | 2007-05-18 | 2012-12-21 | Tti Ellebeau Inc | Transdermal delivery devices assuring an improved release of an active principle through a biological interface |
JP2010187707A (ja) * | 2007-06-12 | 2010-09-02 | Hokkaido Univ | インスリンを封入したイオントフォレーシス用リポソーム製剤 |
US20090043244A1 (en) * | 2007-08-08 | 2009-02-12 | Inan Omer T | Electrotransport Drug Delivery Device Adaptable to Skin Resistance Change |
US20090105634A1 (en) * | 2007-10-17 | 2009-04-23 | Alza Corporation | Anodic Reservoir for Electrotransport of Cationic Drug |
US20090105632A1 (en) * | 2007-10-18 | 2009-04-23 | Padmanabhan Rama V | Electrotransport Of Lisuride |
US20090312689A1 (en) * | 2008-06-05 | 2009-12-17 | Alza Corporation | Adjustable Current Electrotransport Fentanyl Delivery Device |
AR073575A1 (es) * | 2008-09-10 | 2010-11-17 | Transcu Ltd | Aparato y metodo para dispensar basados en hpc liquidos viscosos en sustratos porosos por ejemplo proceso continuo basado en bandas |
US8048442B1 (en) | 2008-09-16 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Modified heparin-based coatings and related drug eluting stents |
US8428708B1 (en) | 2012-05-21 | 2013-04-23 | Incline Therapeutics, Inc. | Self-test for analgesic product |
US8428709B1 (en) | 2012-06-11 | 2013-04-23 | Incline Therapeutics, Inc. | Current control for electrotransport drug delivery |
US8301238B2 (en) | 2011-03-31 | 2012-10-30 | Incline Therapeutics, Inc. | Two-part electrotransport device |
US9855211B2 (en) * | 2013-02-28 | 2018-01-02 | Novan, Inc. | Topical compositions and methods of using the same |
US10478498B2 (en) | 2014-06-20 | 2019-11-19 | Reform Biologics, Llc | Excipient compounds for biopolymer formulations |
GB2533827B (en) * | 2015-05-21 | 2016-12-21 | Gateway Devices Ltd | Intravenous access device |
WO2017069910A2 (en) * | 2015-09-25 | 2017-04-27 | Massachusetts Institute Of Technology | Stretchable, robust and biocompatible hydrogel electronics and devices |
WO2018013673A1 (en) * | 2016-07-13 | 2018-01-18 | Reform Biologics, Llc | Stabilizing excipients for therapeutic protein formulations |
CN106491517B (zh) * | 2016-11-23 | 2019-12-06 | 佛山科学技术学院 | 吡非尼酮pva水凝胶的制备方法及吡非尼酮pva水凝胶 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0058497B1 (de) * | 1981-02-05 | 1985-08-28 | Nippon Oil Co. Ltd. | Verfahren zum Herstellen eines Hydrogels |
DE3278911D1 (en) * | 1981-05-16 | 1988-09-22 | Nippon Oil Co Ltd | Process for the preparation of gel for use as cooling medium |
US4542013A (en) * | 1981-07-08 | 1985-09-17 | Key Pharmaceuticals, Inc. | Trinitroglycerol sustained release vehicles and preparation therefrom |
US4593053A (en) * | 1984-12-07 | 1986-06-03 | Medtronic, Inc. | Hydrophilic pressure sensitive biomedical adhesive composition |
JPS61218517A (ja) * | 1985-03-25 | 1986-09-29 | Bio Materiaru Yunibaasu:Kk | 経皮吸収製剤 |
EP0303445A1 (de) * | 1987-08-13 | 1989-02-15 | Walton S.A. | Pflaster zur transdermalen Applikation von Cleboprid |
JPH0720544B2 (ja) * | 1988-12-27 | 1995-03-08 | 日本石油株式会社 | Pvaヒドロゲルの製造法及びmriファントム |
US5091185A (en) * | 1990-06-20 | 1992-02-25 | Monsanto Company | Coated veterinary implants |
EP0516026A1 (de) * | 1991-05-28 | 1992-12-02 | Takeda Chemical Industries, Ltd. | Hydrogel und Verfahren zu seiner Herstellung |
US5260066A (en) * | 1992-01-16 | 1993-11-09 | Srchem Incorporated | Cryogel bandage containing therapeutic agent |
WO1998008492A1 (en) * | 1996-08-29 | 1998-03-05 | Novo Nordisk A/S | Transdermal delivery of peptides |
US6650934B2 (en) * | 1996-12-17 | 2003-11-18 | Alza Corp | Polymeric foam reservoirs for an electrotransport delivery device |
-
1997
- 1997-12-09 US US08/987,372 patent/US6039977A/en not_active Expired - Lifetime
-
1998
- 1998-11-17 TW TW087119029A patent/TWI231214B/zh not_active IP Right Cessation
- 1998-11-20 ZA ZA9810641A patent/ZA9810641B/xx unknown
- 1998-12-01 JP JP2000524017A patent/JP2001525377A/ja active Pending
- 1998-12-01 AU AU15357/99A patent/AU1535799A/en not_active Abandoned
- 1998-12-01 WO PCT/US1998/025120 patent/WO1999029348A1/en active IP Right Grant
- 1998-12-01 CN CNB988120623A patent/CN1147319C/zh not_active Expired - Fee Related
- 1998-12-01 DK DK98959589T patent/DK1037667T3/da active
- 1998-12-01 PT PT98959589T patent/PT1037667E/pt unknown
- 1998-12-01 AT AT98959589T patent/ATE266422T1/de not_active IP Right Cessation
- 1998-12-01 DE DE69823869T patent/DE69823869T2/de not_active Expired - Lifetime
- 1998-12-01 KR KR1020007006165A patent/KR100568482B1/ko not_active IP Right Cessation
- 1998-12-01 EP EP98959589A patent/EP1037667B1/de not_active Expired - Lifetime
- 1998-12-01 ES ES98959589T patent/ES2221228T3/es not_active Expired - Lifetime
- 1998-12-01 CA CA002313642A patent/CA2313642C/en not_active Expired - Fee Related
- 1998-12-07 AR ARP980106205A patent/AR017197A1/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US6039977A (en) | 2000-03-21 |
PT1037667E (pt) | 2004-08-31 |
DK1037667T3 (da) | 2004-09-20 |
KR20010032839A (ko) | 2001-04-25 |
CA2313642C (en) | 2008-09-30 |
JP2001525377A (ja) | 2001-12-11 |
CN1147319C (zh) | 2004-04-28 |
AU1535799A (en) | 1999-06-28 |
ES2221228T3 (es) | 2004-12-16 |
ZA9810641B (en) | 1999-05-24 |
EP1037667B1 (de) | 2004-05-12 |
DE69823869T2 (de) | 2005-05-19 |
WO1999029348A1 (en) | 1999-06-17 |
TWI231214B (en) | 2005-04-21 |
EP1037667A1 (de) | 2000-09-27 |
CA2313642A1 (en) | 1999-06-17 |
KR100568482B1 (ko) | 2006-04-07 |
CN1281372A (zh) | 2001-01-24 |
ATE266422T1 (de) | 2004-05-15 |
AR017197A1 (es) | 2001-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69823869D1 (de) | Pharmazeutische hydrogelformulierungen, vorrichtungen zur arzneistoffabgabe und verfahren | |
ATE516812T1 (de) | Pharmazeutische formulierungen zur anhaltenden arzneimittelfreisetzung | |
DE69909801D1 (de) | Oral verabreichtes system zur zeitlich und räumlich gesteuerten arzneistoffabgabe | |
DE69935681D1 (de) | Vorrichtungen zur Medikamentverabreichung | |
ATE234078T1 (de) | Pharmazeutische omeprazol-formulierung | |
EP1432466A4 (de) | Injektorvorrichtung auf mikronadelbasis zur arzneimittelabgabe und verwendungsverfahren dafür | |
HU9800863D0 (en) | Drug delivery system for two or more active substances | |
EE05506B1 (et) | Ravimi manustamise vahend eriti progestiinide jastrogeenide manustamiseks | |
EE200100714A (et) | Farmatseutiliste ravimvormide pihustamissüsteemidja -meetodid | |
DE69730475D1 (de) | Beschichteter Stent und Verfahren zur Wirkstoffabgabe | |
DE60013445D1 (de) | Pharmazeutische dosierungsformen zur kontrollierter pulsierender abgabe | |
NO961136D0 (no) | Farmasöytisk formuleringsgrunnlag for nano-suspensjoner | |
EP1036573A4 (de) | Gerät zum verabreichen einer substanz durch die haut oder eine schleimhaut | |
HUP0104687A3 (en) | Methods for preparing coated drug particles and pharmaceutical formulations thereof | |
DE60037816D1 (de) | Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka | |
EP1221926A4 (de) | Pharmazeutische zusammensetzungen mit schlecht löslichen arzneimittelwirkstoffen | |
DE60010113D1 (de) | N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
ZA981775B (en) | Pharmaceutical formulations containing poorly soluble drug substances | |
LT99148A (en) | Drug delivery devices and pharmaceutical composition for treatment wasting syndromes | |
AUPP854499A0 (en) | Device and method for anterior segment drug delivery | |
ZA200103829B (en) | Methods for preparing coated drug particles and pharmaceutical formulations thereof. | |
PT996436E (pt) | Formulacoes farmaceuticas contendo substancias medicamentosas francamente soluveis | |
AUPR313801A0 (en) | Device and method for anterior segment drug delivery | |
AUPQ552200A0 (en) | Device and method for anterior segment drug delivery | |
GB0002342D0 (en) | Apparatus and method for drug administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |